Neutrophil-lymphocyte ratio (NLR) was associated with prognosis and immunomodulatory in patients with pancreatic ductal adenocarcinoma (PDAC)

被引:23
|
作者
Xiang, Zi-jun [1 ]
Hu, Tao [2 ]
Wang, Yun [1 ]
Wang, Hao [1 ]
Xu, Lin [3 ]
Cui, Ning [3 ]
机构
[1] Taihe Hosp, Ctr Liver Biliary Pancreat, Shiyan City, Hubei, Peoples R China
[2] Zhuxi Peoples Hosp, Dept Radiol, Shiyan City, Hubei, Peoples R China
[3] Taihe Hosp, Med Imaging Ctr Intervent Room, Shiyan City, Hubei, Peoples R China
关键词
CANCER; RESECTION; CYTOKINES; SURVIVAL; CELLS; INDEX;
D O I
10.1042/BSR20201190
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although the oncological outcomes in patients with pancreatic ductal adenocarcinoma (PDAC) have markedly improved over the past decade, the survival prediction is still challenging. The aim of this study was to investigate the prognostic value of neutrophil-lymphocyte ratio (NLR) and analyze the relationship of between the NLR and immune cells phenotypes in patients with PDAC. Sixty-seven consecutive patients with PDAC were recruited in this study. Life-table estimates of survival time were calculated according to the Kaplan and Meier methodology. The phenotypic T cells subclasses were evaluated by flow cytometry. All the 67 patients in this study were treated with surgical resection and among them, 46 patients received adjuvant chemotherapy. Receiver operating characteristic (ROC) curves analysis was performed to compare prognostic value of NLR with CA199. We found that the Harrell's area under ROC (AUROC) for the NLR to predict overall survival (OS) (0.840; 95% CI, 0.766-0.898) was significantly higher than that of the CA199 levels. After that we stratified all patients into NLR > 2.5 (n = 42) and NLR <= 2.5 (n = 25) groups according to the OS of patients with PDAC. Survival analysis showed that patients with NLR <= 2.5 had significantly favorable OS and progressive free survival (PFS) compared with patients with NLR 2.5. The CD3+ and CD8+/CD28+ T cell subsets were significantly increased in patients with NLR <= 2.5 (P< 0.05), while the CD8+/CD28- and CD4+/CD25+ cell subsets were significantly decreased in patients with NLR <= 2.5 (P., 0.05). In conclusion, a high NLR value independently predicts poor survival in patients with PDAC after surgical resection. The NLR was closely related with immune cells phenotypes The NLR may help oncologists evaluate outcomes of patients received surgical resection and chemotherapy to choose alternative therapies for patients with high NLR value.
引用
收藏
页数:8
相关论文
共 50 条
  • [31] Neutrophil-Lymphocyte Ratio as a Novel Biomarker of Prognosis in Patients With Heart Failure
    Mi, Wenzhen
    Li, Tai
    ANGIOLOGY, 2024, 75 (08) : 798 - 799
  • [32] The predictive role of the neutrophil-lymphocyte ratio in the prognosis of adult patients with stroke
    Wan J.
    Wang X.
    Zhen Y.
    Chen X.
    Yao P.
    Liu W.
    Lu E.
    Du Y.
    Liu H.
    Zhao S.
    Chinese Neurosurgical Journal, 6 (1)
  • [33] Prognostic Value of the Prediagnostic Neutrophil-Lymphocyte Ratio (NLR) for the Survival of Patients With Lung Cancer
    Bar Ad, V.
    Lai, Y.
    Lu, B.
    Palmer, J.
    Myers, R.
    Ye, Z.
    Wang, C.
    Axelrod, R.
    Campling, B.
    Werner-Wasik, M.
    Cowan, S.
    Evans, N.
    Kumar, R.
    Hehn, B.
    Solomides, C.
    Yang, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S78 - S78
  • [34] Association of the neutrophil-lymphocyte ratio (NLR) with outcomes in patients admitted for an acute coronary syndrome
    Aherrera, Jaime Alfonso M.
    Chiong, Lowe
    Reganit, Paul
    Punzalan, Felix
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C135 - C136
  • [35] Association of The Neutrophil-Lymphocyte Ratio (Nlr) with Outcomes in Patients Admitted for An Acute Coronary Syndrome
    Aherrera, Jaime Alfonso M.
    Chiong, Lowe
    Ferdinand Reganit, Paul
    Eduardo Punzalan, Felix
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2014, 21 : S1 - S1
  • [36] Neutrophil-Lymphocyte Ratio in Patients with Adenoidectomy
    Derin, Serhan
    Erdogan, Selvet
    Sahan, Murat
    Topal, Hatice
    Sozen, Hamdi
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (03) : MC3 - MC5
  • [37] Optimal cutpoint of preoperative neutrophil-lymphocyte ratio and associated postoperative prognosis in colorectal cancer patients
    Chiu, Tai-Jan
    Liu, Ting-Ting
    Chang, Ching-Di
    Hu, Wan-Hsiang
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2025, 40 (01)
  • [38] Prognostic value of neutrophil-lymphocyte ratio in patients with advanced pancreatic cancer
    Ben Kridis, W.
    Lajnef, M.
    Khmiri, S.
    Khanfir, A.
    ANNALS OF ONCOLOGY, 2021, 32 : S1357 - S1357
  • [39] Prognostic value of neutrophil-lymphocyte ratio in first line treatment for metastatic pancreatic adenocarcinoma
    Rho, Y. S.
    Ranger, J.
    Hamalova, S.
    Barrera, I.
    Mamo, A.
    Batist, G.
    Kavan, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [40] Influence of neutrophil-lymphocyte ratio in prognosis of glioblastoma multiforme
    Lopes, Marta
    Carvalho, Bruno
    Vaz, Rui
    Linhares, Paulo
    JOURNAL OF NEURO-ONCOLOGY, 2018, 136 (01) : 173 - 180